Tenaya Therapeutics (TNYA) Market Capitalization (2021 - 2026)

Tenaya Therapeutics has reported Market Capitalization for 6 years, with the latest figure at $165.9 million in Q2 2026.

• On a quarterly basis, Market Capitalization rose 66.58% year-over-year to $165.9 million in Q2 2026; TTM through Jun 2026 was $165.9 million, a 66.58% increase from a year earlier, with the FY2025 full-year figure at $108.8 million, down 12.05% from the prior year.
• Market Capitalization was $165.9 million for Q2 2026 at Tenaya Therapeutics, up from $150.3 million in the prior quarter.
• The five-year high for Market Capitalization was $486.6 million in Q1 2022, with the low at $62.6 million in Q1 2025.
• Average Market Capitalization over 5 years is $205.7 million, with a median of $169.8 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Market Capitalization surged 145.73% in 2023, then slumped 84.75% in 2025.
• Over 5 years, Market Capitalization stood at $90.1 million in 2022, then soared by 145.73% to $221.4 million in 2023, then slumped by 44.1% to $123.8 million in 2024, then declined by 12.05% to $108.8 million in 2025, then soared by 52.45% to $165.9 million in 2026.
• The last three Market Capitalization figures came in at $165.9 million (Q2 2026), $150.3 million (Q1 2026), and $108.8 million (Q4 2025), per Business Quant data.